Sana Biotechnology, Inc. (SANA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $71.87M | -43.7% |
| 2024 | $127.57M | -4.5% |
| 2023 | $133.52M | -24.5% |
| 2022 | $176.76M | -30.1% |
| 2021 | $253.03M | +102.7% |
| 2020 | $124.81M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $71.87M | -43.7% |
| 2024 | $127.57M | -4.5% |
| 2023 | $133.52M | -24.5% |
| 2022 | $176.76M | -30.1% |
| 2021 | $253.03M | +102.7% |
| 2020 | $124.81M | — |